{"authors": [["Lowe", "Penelope", "P", "National Psychosis Service, South London and Maudsley NHS Foundation Trust, UK."], ["Krivoy", "Amir", "A", "Psychosis Studies Department, Institute of Psychiatry, Psychology and Neuroscience, 16 De Crespigny Park, London, SE5 8AF, UK."], ["Porffy", "Lilla", "L", "Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK."], ["Henriksdottir", "Erna", "E", "National Psychosis Service, South London and Maudsley NHS Foundation Trust, UK. University of Iceland, Iceland."], ["Eromona", "Whiskey", "W", "National Psychosis Service, South London and Maudsley NHS Foundation Trust, UK. Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK."], ["Shergill", "Sukhwinder S", "SS", "National Psychosis Service, South London and Maudsley NHS Foundation Trust, UK. Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK."]], "date": "2017-11-02", "id": "29344345", "text": "Treatment-resistant schizophrenia is a serious clinical problem. We adopt a systems-level approach positing a greater role for cognitive control mechanisms in the development of psychotic symptoms and illustrate the clinical application of this via a case report of treatment-resistant patients treated successfully with adjunct pro-cognitive serotonergic medication.", "doi": "10.1177/2045125317737003", "title": "When the drugs don't work: treatment-resistant schizophrenia, serotonin and serendipity.", "journal": ["Therapeutic advances in psychopharmacology", "Ther Adv Psychopharmacol"]}